RT Book, Section
A1 Yotsu, Rie Roselyne
A1 Ishii, Norihisa
A1 Rajagopalan, Shobita
A2 Kelly, A. Paul
A2 Taylor, Susan C.
A2 Lim, Henry W.
A2 Serrano, Ana Maria Anido
SR Print(0)
ID 1161548632
T1 Leprosy
T2 Taylor and Kelly's Dermatology for Skin of Color, 2e
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 9780071805520
LK dermatology.mhmedical.com/content.aspx?aid=1161548632
RD 2024/04/19
AB KEY  POINTSLeprosy  is  a  mycobacterial  infection  that  affects  the  skin  and  the  peripheral  nerves.There  are  over  200,000  new  cases  of  leprosy  diagnosed  every  year  around  the  world.Various  skin  symptoms  are  associated  with  the  disease  depending  on  the  immune  reaction  of  the  host  (patient),  including  hypopigmentation,  erythema,  and  nodules.Multidrug  therapy,  which  is  a  combination  of  dapsone,  rifampicin,  and  clofazimine,  effectively  cures  the  disease  and  is  recommended  as  the  first-line  therapy  by  the  World  Health  Organization.Deformities  as  a  consequence  of  the  disease  lead  to  social  discrimination  and  stigma  and,  hence,  the  need  for  early  detection  and  treatment.